New Hampshire SB455 mandates Medicaid coverage for GLP-1 medication for qualifying patients.

New Hampshire SB455 amends the state Medicaid plan to include coverage for GLP-1 medication. This coverage applies if a licensed health care provider determines the medication is medically necessary and the patient meets specific criteria. These criteria include having a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with certain weight-related conditions such as Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or metabolic dysfunction associated steatotic liver disease.

New Hampshire SB455 mandates Medicaid coverage for GLP-1 medication for qualifying patients.

New Hampshire SB455 amends the state Medicaid plan to include coverage for GLP-1 medication. This coverage applies if a licensed health care provider determines the medication is medically necessary and the patient meets specific criteria. These criteria include having a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with certain weight-related conditions such as Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or metabolic dysfunction associated steatotic liver disease.